Zhejiang Gongdong Medical Technology Co Ltd (605369) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Zhejiang Gongdong Medical Technology Co Ltd (605369) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥59.82 Million ≈ $8.75 Million USD) by net assets (CN¥1.73 Billion ≈ $253.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 605369 net asset quality index to measure how much of total assets are equity-financed.

Zhejiang Gongdong Medical Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Zhejiang Gongdong Medical Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Zhejiang Gongdong Medical Technology Co to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Gongdong Medical Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Gongdong Medical Technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Hainan RuiZe New Building Material Co Ltd
SHE:002596
-0.008x
Shandong Shengli Co Ltd
SHE:000407
0.110x
Altice USA Inc
NYSE:ATUS
-0.066x
Pansoft Company Limited
SHE:300996
N/A
Bradespar S.A
SA:BRAP3
0.069x
Mill City Ventures III Ltd
NASDAQ:MCVT
0.015x
TPI Polene Public Company Limited
BK:TPIPL
0.015x
Shandong Oriental Ocean Sci-Tech Co Ltd
SHE:002086
-0.035x

Annual Cash Flow Conversion Efficiency for Zhejiang Gongdong Medical Technology Co Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Gongdong Medical Technology Co Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see 605369 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.71 Billion
≈ $249.68 Million
CN¥253.96 Million
≈ $37.16 Million
0.149x +21.51%
2024-12-31 CN¥1.72 Billion
≈ $251.33 Million
CN¥210.38 Million
≈ $30.79 Million
0.122x +8.26%
2023-12-31 CN¥1.64 Billion
≈ $239.77 Million
CN¥185.39 Million
≈ $27.13 Million
0.113x -36.29%
2022-12-31 CN¥1.59 Billion
≈ $232.99 Million
CN¥282.75 Million
≈ $41.38 Million
0.178x -33.91%
2021-12-31 CN¥1.39 Billion
≈ $203.11 Million
CN¥372.99 Million
≈ $54.58 Million
0.269x +34.03%
2020-12-31 CN¥1.21 Billion
≈ $176.76 Million
CN¥242.18 Million
≈ $35.44 Million
0.200x -33.58%
2019-12-31 CN¥405.25 Million
≈ $59.30 Million
CN¥122.33 Million
≈ $17.90 Million
0.302x +0.63%
2018-12-31 CN¥341.42 Million
≈ $49.96 Million
CN¥102.42 Million
≈ $14.99 Million
0.300x -11.44%
2017-12-31 CN¥252.52 Million
≈ $36.95 Million
CN¥85.54 Million
≈ $12.52 Million
0.339x -26.02%
2016-12-31 CN¥188.07 Million
≈ $27.52 Million
CN¥86.12 Million
≈ $12.60 Million
0.458x --

About Zhejiang Gongdong Medical Technology Co Ltd

SHG:605369 China Medical Instruments & Supplies
Market Cap
$502.04 Million
CN¥3.43 Billion CNY
Market Cap Rank
#12005 Global
#3356 in China
Share Price
CN¥15.56
Change (1 day)
+2.84%
52-Week Range
CN¥15.13 - CN¥22.50
All Time High
CN¥103.53
About

Zhejiang Gongdong Medical Technology Co., Ltd. researches, develops, produces, and sells disposable medical consumables in China. Its products include blood collection tubes, needles and needle holders, and sharp containers; cell culture dishes, plates, bottles, flasks, and serological pipette solutions; laboratory consumables, such as petri dishes, centrifuge and cryo tubes, pipette tips, transf… Read more